In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all
current investors, traders, and shareholders of Walker &
Dunlop, Inc. (NYSE:WD), Vanda Pharmaceuticals Inc. (NASDAQ:VNDA),
Acushnet Holdings Corp. (NYSE:GOLF), SS&C Technologies
Holdings, Inc. (NASDAQ:SSNC), ManpowerGroup (NYSE:MAN), and Glaukos
Corporation (NYSE:GKOS), including updated fundamental summaries,
consolidated fiscal reporting, and fully-qualified certified
analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
WD DOWNLOAD:
http://Fundamental-Markets.com/register/?so=WD VNDA
DOWNLOAD: http://Fundamental-Markets.com/register/?so=VNDA GOLF
DOWNLOAD: http://Fundamental-Markets.com/register/?so=GOLF SSNC
DOWNLOAD: http://Fundamental-Markets.com/register/?so=SSNC MAN
DOWNLOAD: http://Fundamental-Markets.com/register/?so=MAN GKOS
DOWNLOAD:
http://Fundamental-Markets.com/register/?so=GKOS
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Fundamental
Markets, available for free download at the links above, examine
Walker & Dunlop, Inc. (NYSE:WD), Vanda Pharmaceuticals Inc.
(NASDAQ:VNDA), Acushnet Holdings Corp. (NYSE:GOLF), SS&C
Technologies Holdings, Inc. (NASDAQ:SSNC), ManpowerGroup
(NYSE:MAN), and Glaukos Corporation (NYSE:GKOS) on a fundamental
level and outlines the overall demand for their products and
services in addition to an in-depth review of the business
strategy, management discussion, and overall direction going
forward. Several excerpts from the recently released reports are
available to today's readers below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. All
information in this release was accessed November 24th, 2017.
Please download the entire research report, free of charge, to
ensure you are reading all relevant material information. All
amounts in millions (except per share amounts).
-----------------------------------------
WALKER & DUNLOP, INC. (WD)
REPORT OVERVIEW
Walker & Dunlop's Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Walker & Dunlop reported revenue of
$179.74 vs $154.79 (up 16.12%) and diluted earnings per share $1.06
vs $0.96 (up 10.42%). For the twelve months ended December 31st,
2016 vs December 31st, 2015, Walker & Dunlop reported revenue
of $575.28 vs $468.20 (up 22.87%) and diluted earnings per share
$3.65 vs $2.65 (up 37.74%). Walker & Dunlop is expected to
report earnings on February 14th, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the
same quarter last year was $1.16. The estimated EPS forecast for
the next fiscal year is $4.41 and is expected to report on February
14th, 2018.
To read the full Walker & Dunlop, Inc. (WD) report, download
it here:
http://Fundamental-Markets.com/register/?so=WD
-----------------------------------------
VANDA PHARMACEUTICALS INC. (VNDA)
REPORT OVERVIEW
Vanda Pharmaceuticals' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Vanda Pharmaceuticals reported revenue of
$41.34 vs $38.48 (up 7.42%) and diluted earnings per share -$0.10
vs -$0.01. For the twelve months ended December 31st, 2016 vs
December 31st, 2015, Vanda Pharmaceuticals reported revenue of
$146.02 vs $109.93 (up 32.83%) and diluted earnings per share
-$0.41 vs -$0.94. Vanda Pharmaceuticals is expected to report
earnings on February 21st, 2018. The report will be for the fiscal
period ending December 31st, 2017. The reported EPS for the same
quarter last year was $0.04. The estimated EPS forecast for the
next fiscal year is -$0.13 and is expected to report on February
21st, 2018.
To read the full Vanda Pharmaceuticals Inc. (VNDA) report,
download it here:
http://Fundamental-Markets.com/register/?so=VNDA
-----------------------------------------
ACUSHNET HOLDINGS CORP. (GOLF) REPORT
OVERVIEW
Acushnet's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Acushnet reported revenue of $347.26 vs
$339.32 (up 2.34%) and diluted earnings per share $0.12 vs -$0.38.
For the twelve months ended December 31st, 2016 vs December 31st,
2015, Acushnet reported revenue of $1,572.28 vs $1,502.96 (up
4.61%) and diluted earnings per share $0.62 vs -$0.74. Acushnet is
expected to report earnings on March 29th, 2018. The report will be
for the fiscal period ending December 31st, 2017. The reported EPS
for the same quarter last year was -$0.02. The estimated EPS
forecast for the next fiscal year is $1.27 and is expected to
report on March 29th, 2018.
To read the full Acushnet Holdings Corp. (GOLF) report, download
it here:
http://Fundamental-Markets.com/register/?so=GOLF
-----------------------------------------
SS&C TECHNOLOGIES HOLDINGS, INC.
(SSNC) REPORT OVERVIEW
SS&C Technologies' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, SS&C Technologies reported revenue of
$418.25 vs $383.30 (up 9.12%) and diluted earnings per share $0.30
vs $0.19 (up 57.89%). For the twelve months ended December 31st,
2016 vs December 31st, 2015, SS&C Technologies reported revenue
of $1,481.44 vs $1,000.29 (up 48.10%) and diluted earnings per
share $0.64 vs $0.22 (up 190.91%). SS&C Technologies is
expected to report earnings on February 21st, 2018. The report will
be for the fiscal period ending December 31st, 2017. The reported
EPS for the same quarter last year was $0.44. The estimated EPS
forecast for the next fiscal year is $2.02 and is expected to
report on February 21st, 2018.
To read the full SS&C Technologies Holdings, Inc. (SSNC)
report, download it here:
http://Fundamental-Markets.com/register/?so=SSNC
-----------------------------------------
MANPOWERGROUP (MAN) REPORT
OVERVIEW
ManpowerGroup's Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, ManpowerGroup reported revenue of
$5,464.80 vs $5,088.20 (up 7.40%) and diluted earnings per share
$2.04 vs $1.87 (up 9.09%). For the twelve months ended December
31st, 2016 vs December 31st, 2015, ManpowerGroup reported revenue
of $19,654.10 vs $19,329.90 (up 1.68%) and diluted earnings per
share $6.27 vs $5.40 (up 16.11%). ManpowerGroup is expected to
report earnings on January 30th, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the
same quarter last year was $1.80. The estimated EPS forecast for
the next fiscal year is $7.61 and is expected to report on January
30th, 2018.
To read the full ManpowerGroup (MAN) report, download it here:
http://Fundamental-Markets.com/register/?so=MAN
-----------------------------------------
GLAUKOS CORPORATION (GKOS) REPORT
OVERVIEW
Glaukos' Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Glaukos reported revenue of $40.41 vs
$29.58 (up 36.63%) and diluted earnings per share $0.04 vs $0.03
(up 33.33%). For the twelve months ended December 31st, 2016 vs
December 31st, 2015, Glaukos reported revenue of $114.40 vs $71.70
(up 59.55%) and diluted earnings per share $0.12 vs -$2.13. Glaukos
is expected to report earnings on March 7th, 2018. The report will
be for the fiscal period ending December 31st, 2017. The reported
EPS for the same quarter last year was $0.00. The estimated EPS
forecast for the next fiscal year is $0.13 and is expected to
report on March 7th, 2018.
To read the full Glaukos Corporation (GKOS) report, download it
here:
http://Fundamental-Markets.com/register/?so=GKOS
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members
and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best
information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial
experience and includes top financial writers, FINRA® BrokerCheck®
certified professionals with current and valid CRD® number
designations, as well as Chartered Financial Analyst® (CFA®)
designation holders, to ensure up to date factual information for
active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff
are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and
registered FINRA® members holding duly issued CRD® numbers. Current
licensed status of several Registered Members at Fundamental
Markets have been independently verified by an outside audit firm,
including policy and audit records duly executed by Registered
Members. Complaints, concerns, questions, or inquiries regarding
this release should be directed to Fundamental Markets' Compliance
department by Phone, at +1 667-401-0010, or by E-mail at
compliance@fundamental-markets.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets
affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no
representations as to the completeness, accuracy, or timeliness of
the material provided and all materials are subject to change
without notice. Fundamental Markets has not been compensated for
the publication of this press release by any of the above mentioned
companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any
activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our
website.
Media Contact: Andrew Duffie, Media Department
Office: +1 667-401-0010 E-mail:
andrew.duffie@fundamental-markets.com
Ⓒ 2017 Fundamental Markets. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@fundamental-markets.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.
Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From Apr 2024 to May 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From May 2023 to May 2024